Home NewsAfrica UNGA: AfDB President insists on development of Africa’s manufacturing capacity

UNGA: AfDB President insists on development of Africa’s manufacturing capacity

by Haruna Gimba

By Zayamu Hassan

The President of the African Development Bank (AfDB), Akinwumi A. Adesina, has insisted that Africa cannot outsourced its health needs to the rest of the world.

He, therefore, emphasized the need to build Africa’s manufacturing and healthcare capacity.

Speaking in a panel that looked at balancing the scales of global health and the consequences of the coronavirus, at the United Nations General Assembly, Adesina noted that: “Africa cannot outsource its health to the rest of the world. We’ve got to build Africa’s indigenous manufacturing capacity.…we need to secure ourselves.”

The World Trade Organization (WTO) Director-General, Ngozi Okonjo-Iweala, and Global Infrastructure Partners vice chairman and partner Jim Yong Kim, were part of the panel.

The Future Investment Initiative Institute hosted the virtual event as part of a series of panel sessions around the themes of vaccines, resilience and global health.

Adesina said the AfDB would contribute $3 billion to the development of Africa’s pharmaceutical industry over the next 10 years.

“What is needed in the long term is building Africa’s pharmaceutical capacity,” the African Development Bank head stressed.

Responding to a question on what the world leaders were doing to close the dangerous health gap, Okonjo-Iweala said that her top two priorities were to get countries who have an excess of vaccines to donate them to COVAX – the initiative led by the Coalition for Epidemic Preparedness Innovations, the Vaccine Alliance Gavi and the World Health Organization (WHO).

The second, she said, was to “get richer countries to swap places with poorer countries on the waiting list for vaccines.”

In the long term, Okonjo-Iweala said, it was about building Africa’s capacity to manufacture. “We need to decentralize manufacturing,” she stressed.

Standing in the way of that capacity are the various restrictions and trade barriers, intellectual property rights and lack of raw materials, which are making it even harder for African countries to get into the game.

“We are taking action, supply chains for vaccines are very ccomplicated, making sure supply chains flow. We need to lift restrictions so that manufacturers can get what they need.

 “Vaccine nationalism doesn’t pay. We’ve got to let technology be transferred. We can’t be selfish in this pandemic. Lives are at stake,” Okonjo-Iweala said.

On the same issue, Jim Yong Kim decried the lack of leadership in the present global health crisis.

“Where is the coalition that will say this is an unprecedented challenge? What we now need is leadership. We had a similar problem treating people with HIV, we can solve them for the vaccine shortage,” Kim said.

Another theme running through the sessions was the business case for investing in vaccine creation facilities and the benefits to financiers’ bottom line. “You’ve got to have the conversation…it’s in your interest that Africa gets vaccines,” Kim emphasized.

In the opening panel, Carlyle Group co-founder and co-chairman David M. Rubenstein and BNY Mellon CEO Thomas Gibbons acknowledged that profits did not remove the moral imperative to address the inequality between developed and developing nations.

“Vaccines are the most important tool – we have to make vaccine access for all,” Gibbons said.

Internationally acclaimed conservationist and scientist Jane Goodall spoke of the need to create a better world for all in her session entitled “Health in the Anthropocene.”

“We’ve got to ramp up recycling move towards a circular economy. We must remember that each one of us matters. It’s millions of small ethical choices in how we live. We know what we need to do. We need to have the strength and will.”

Related Articles

Leave a Comment